BIIB - Biogen Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 556.42B
Enterprise Value 358.7B
Trailing P/E 10.32
Forward P/E 19.95
PEG Ratio (5 yr expected) 12.65
Price/Sales (ttm)3.92
Price/Book (mrq)4.23
Enterprise Value/Revenue 34.08
Enterprise Value/EBITDA 67.58

Trading Information

Stock Price History

Beta (5Y Monthly) 1.17
52-Week Change 3-0.88%
S&P500 52-Week Change 315.52%
52 Week High 3374.99
52 Week Low 3215.78
50-Day Moving Average 3305.81
200-Day Moving Average 3272.70

Share Statistics

Avg Vol (3 month) 31.78M
Avg Vol (10 day) 31.5M
Shares Outstanding 5174.06M
Float 173.05M
% Held by Insiders 10.62%
% Held by Institutions 191.14%
Shares Short (Jan 30, 2020) 43.11M
Short Ratio (Jan 30, 2020) 42.13
Short % of Float (Jan 30, 2020) 41.61%
Short % of Shares Outstanding (Jan 30, 2020) 41.79%
Shares Short (prior month Dec 30, 2019) 44.33M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 23:1
Last Split Date 3Jan 17, 2001

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Dec 30, 2019

Profitability

Profit Margin 40.96%
Operating Margin (ttm)50.60%

Management Effectiveness

Return on Assets (ttm)17.31%
Return on Equity (ttm)44.66%

Income Statement

Revenue (ttm)14.38B
Revenue Per Share (ttm)76.85
Quarterly Revenue Growth (yoy)4.10%
Gross Profit (ttm)12.42B
EBITDA 7.74B
Net Income Avi to Common (ttm)5.89B
Diluted EPS (ttm)31.42
Quarterly Earnings Growth (yoy)52.10%

Balance Sheet

Total Cash (mrq)4.48B
Total Cash Per Share (mrq)25.71
Total Debt (mrq)6.44B
Total Debt/Equity (mrq)48.29
Current Ratio (mrq)1.72
Book Value Per Share (mrq)76.60

Cash Flow Statement

Operating Cash Flow (ttm)7.08B
Levered Free Cash Flow (ttm)4.64B